 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| semaglutide once weekly (NN9904) / Novo Nordisk
Enrollment open: Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese Participants (clinicaltrials.gov) - Oct 30, 2023
P1, N=170, Recruiting, Sponsor: Novo Nordisk A/S
Not yet recruiting --> Recruiting
- ||| semaglutide once weekly (NN9904) / Novo Nordisk
New P1 trial: Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese Participants (clinicaltrials.gov) - Oct 5, 2023
P1, N=170, Not yet recruiting, Sponsor: Novo Nordisk A/S
- ||| semaglutide once weekly (NN9904) / Novo Nordisk
Trial completion: A Research Study of a New Medicine NNC0113-6856 in Healthy Males (clinicaltrials.gov) - Mar 30, 2023
P1, N=70, Completed, Sponsor: Novo Nordisk A/S
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| semaglutide once weekly (NN9904) / Novo Nordisk
Enrollment open: A Research Study of a New Medicine NNC0113-6856 in Healthy Males (clinicaltrials.gov) - Sep 10, 2022
P1, N=70, Recruiting, Sponsor: Novo Nordisk A/S
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||| semaglutide once weekly (NN9904) / Novo Nordisk
New P1 trial: A Research Study of a New Medicine NNC0113-6856 in Healthy Males (clinicaltrials.gov) - Aug 30, 2022
P1, N=70, Not yet recruiting, Sponsor: Novo Nordisk A/S